4Gismondo M R, Drago L, Fassina M C, et al. Immunostimulating effect of oral glutamine. Dig Dis Sci 1998,43(8) : 1752-1754.
5Kaya E, Gur ES, Ozguc H, et al. L-glutamine enemas attenuate mucosal injury in experimental colitis.Dis Colon Rectum 1999,42(9) : 1209-1215.
6Israeli E, Berenshtein E, Wengrower D, et al. Prophylactic administration of topical glutamine enhances the capability of the rat colon to resist inflammatory damage. Dig Dis Sci, 2004, 49(10) : 1705-1712.
7Mourn B,Ekbom A,Vatn MH,et al. Clinical course during the Ist year after diagnosis in ulcerative colitis and Crohn' s disease. Results of a large,prospective population-based study in southeastern Norway, 1990-1993.Scand J Gastroenterol, 1997,32(10) : 1005-1012.
8Rembacken B J, Snelling AM, Hawkey PM, et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis.a randomised trial. Lancet, 1999,354 : 635-639.
9Ameho CK Adjei AA Harrison EK, et al.Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumor necrosis factor alpha production in trinitrobezene sulphonic acid induced colitis. Gut, 1997,41 (4):487-493.
10Rembacken B J, Snelling AM, Hawkey PM, et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis, a randomised trial. Lancet, 1999,354 : 635-639
6Lysy J, Israeli E, Goldin E. The prevalence of chronic diarrhea a-mong diabetic patients. Am J Gastroenterol, 1999 ,94 ( 8 ) :2165-2170.
7TARGOWNIK LE, SINGH H, NUGENT Z, et al. The epidemiology of colectomy in ulcerative colitis:re- sults from a Population-Based cohort[J]. Am J Gastro- enterol, 2012, 107(8) : 1228- 1235.
8DANESE S, FIOCCHI C. Ulcerative colitis[J]. N Engl J Med, 2011, 365(18):1713-1725.
9MOWAT C, COLE A, WINDSOR A, et al. Guidelines for the management of inflammatory bowel disease in adults[J]. Gut, 2011, 60(5) : 571- 607.
